SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-06-001063
Filing Date
2006-11-14
Accepted
2006-11-14 16:39:21
Documents
6
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a25104e10vq.htm 10-Q 646860
2 EXHIBIT 10.298 a25104exv10w298.htm EX-10.298 4477
3 EXHIBIT 31.1 a25104exv31w1.htm EX-31.1 6512
4 EXHIBIT 31.2 a25104exv31w2.htm EX-31.2 6502
5 EXHIBIT 32.1 a25104exv32w1.htm EX-32.1 3644
6 EXHIBIT 32.2 a25104exv32w2.htm EX-32.2 3634
  Complete submission text file 0000936392-06-001063.txt   673041
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 061215898
SIC: 2834 Pharmaceutical Preparations